Sandu Pharmaceuticals Limited (BOM:524703)

Sandu Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 4, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	382	473	554	593	620	253
Market Cap Growth	-31.86%	-14.64%	-6.51%	-4.32%	144.92%	204.17%
Enterprise Value	349	445	512	532	582	212
Last Close Price	39.50	48.19	55.75	50.20	66.93	30.10
PE Ratio	23.52	30.50	37.94	39.01	39.00	23.17
PS Ratio	0.57	0.70	0.82	0.91	0.95	0.43
PB Ratio	0.90	1.13	1.37	1.51	1.70	0.76
P/TBV Ratio	0.90	1.13	1.37	1.51	1.70	0.76
P/FCF Ratio	156.46	4550.88	-	-	575.52	3.39
P/OCF Ratio	34.60	49.90	72.96	268.24	65.33	3.33
EV/Sales Ratio	0.52	0.66	0.76	0.81	0.89	0.36
EV/EBITDA Ratio	12.38	17.52	24.03	22.90	21.61	10.69
EV/EBIT Ratio	16.27	21.25	29.90	27.02	24.85	13.21
EV/FCF Ratio	143.04	4279.97	-	-	540.75	2.84
Debt / Equity Ratio	0.01	0.01	0.00	-	-	0.00
Debt / EBITDA Ratio	0.16	0.17	0.03	-	-	0.01
Debt / FCF Ratio	1.84	45.91	-	-	-	0.00
Asset Turnover	1.19	1.24	1.26	1.26	1.36	1.33
Inventory Turnover	3.37	2.59	2.61	2.60	3.38	2.85
Quick Ratio	0.86	0.62	0.58	0.53	0.72	1.37
Current Ratio	2.09	2.18	2.10	1.84	1.99	2.44
Return on Equity (ROE)	3.93%	3.76%	3.66%	4.02%	4.54%	3.48%
Return on Assets (ROA)	2.39%	2.42%	2.01%	2.38%	3.04%	2.27%
Return on Capital (ROIC)	3.19%	3.15%	2.68%	3.25%	4.19%	3.13%
Return on Capital Employed (ROCE)	4.90%	4.80%	4.10%	4.90%	6.30%	4.70%
Earnings Yield	4.28%	3.28%	2.63%	2.56%	2.56%	4.32%
FCF Yield	0.64%	0.02%	-1.20%	-1.43%	0.17%	29.49%
Dividend Yield	2.03%	1.66%	1.44%	1.49%	1.12%	1.66%
Payout Ratio	47.35%	49.81%	49.59%	43.46%	19.94%	-
Buyback Yield / Dilution	-0.98%	-	-2.42%	-10.93%	-20.08%	-
Total Shareholder Return	1.04%	1.66%	-0.98%	-9.44%	-18.96%	1.66%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.